SEC Form 4 · accession 0001179110-17-004503
American Renal Associates Holdings, Inc. · ARA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jonathan L Wilcox
Officer — VP & Chief Financial Officer
Period of report
Mar 10, 2017
Accepted (ET)
Mar 13, 2017 · 5:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001498068
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 10, 2017 | A | 11,501 | $0.00 | A | 15,272 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy Common Stock)F2 | $17.39 | Mar 10, 2017 | A | 19,100 | A | — | Mar 10, 2027 | Common Stock | 19,100 | 19,100 | D |
Explanation of responses
- F1Reflects grant of restricted stock that vests in three equal annual installments beginning on March 10, 2018.
- F2An option that vests in three equal annual installments beginning on March 10, 2018.